perfect answer
The recent trading in the Company’s securities may be a result of market speculation around the
disclosures within the Company’s Quarterly Activities Report and Appendix 4C, announced on 30 January
2025 around the Company’s potential to achieve a significant industry milestone by becoming the first
company to report positive results in a Phase III clinical trial with a CBD product for insomnia, and which
could open up substantial opportunities for partnership discussions and licensing agreements both locally
and globally.
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
0.4¢ |
Change
-0.001(11.1%) |
Mkt cap ! $12.69M | |||
| Open | High | Low | Value | Volume |
| 0.4¢ | 0.4¢ | 0.4¢ | $206 | 51.42K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 39 | 27849377 | 0.4¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.5¢ | 14505736 | 17 |
View Market Depth
| Last trade - 16.10pm 13/06/2025 (20 minute delay) ? |
| AVE (ASX) Chart |